Click in for more news from The Hill {beacon} Health Care The Big Story Insulin legislation gains steam Bipartisan legislation to cap insulin at $35 a month for people with private insurance is gaining momentum. The bill, introduced in March, picked up four more co-sponsors Monday: Sens. Joni Ernst (R-Iowa), John Hickenlooper (D-Colo.), Kevin...
Click in for more news from The Hill {beacon} Health Care The Big Story Insulin legislation gains steam Bipartisan legislation to cap insulin at $35 a month for people with private insurance is gaining momentum. The bill, introduced in March, picked up four more co-sponsors Monday: Sens. Joni Ernst (R-Iowa), John Hickenlooper (D-Colo.), Kevin...
The Food and Drug Administration (FDA) is moving ahead with a safety review of the abortion pill mifepristone, according to an administration official. The move marks a victory for anti-abortion groups that could pave the way for the Trump administration to restrict its use and how it can be distributed. The retrospective analysis of data...
The Food and Drug Administration (FDA) is moving ahead with a safety review of the abortion pill mifepristone, according to an administration official. The move marks a victory for anti-abortion groups that could pave the way for the Trump administration to restrict its use and how it can be distributed. The retrospective analysis of data...
The intoxicating hemp industry and its allies are quickly running out of time to convince Congress to delay or stop a looming ban on their products. Without action, a ban on hemp-derived intoxicants will take effect in November. There's bipartisan interest in disrupting the ban — which was championed by Sen. Mitch McConnell (R-Ky.) and included the last fall's government funding...
The intoxicating hemp industry and its allies are quickly running out of time to convince Congress to delay or stop a looming ban on their products. Without action, a ban on hemp-derived intoxicants will take effect in November. There's bipartisan interest in disrupting the ban — which was championed by Sen. Mitch McConnell (R-Ky.) and included the last fall's government funding...
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Democrats on the lookout for their next ObamaCare With healthcare costs a top concern in this election cycle and enhanced Affordable Care Act (ACA) subsidies going nowhere in Congress, parts of the Democratic establishment see this moment as...
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Democrats on the lookout for their next ObamaCare With healthcare costs a top concern in this election cycle and enhanced Affordable Care Act (ACA) subsidies going nowhere in Congress, parts of the Democratic establishment see this moment as...
Presented by Planned Parenthood {beacon} Health Care Health Care PRESENTED BY The Big Story FDA to review abortion pill safety after sustained GOP ire The Food and Drug Administration (FDA) on Friday said it will be following through with plans to conduct a safety review of the abortion pill mifepristone, responding to months of pressure...
Presented by Planned Parenthood {beacon} Health Care Health Care PRESENTED BY The Big Story FDA to review abortion pill safety after sustained GOP ire The Food and Drug Administration (FDA) on Friday said it will be following through with plans to conduct a safety review of the abortion pill mifepristone, responding to months of pressure...
Click in for more news from The Hill {beacon} Health Care The Big Story Voters lean in favor of codifying Trump's MFN policy A new poll shows there is strong bipartisan support among battleground voters for Congress to codify President Trump’s “most favored nation” drug pricing policy, which would require pharmaceutical companies to lower the prices they charge Americans to...
Click in for more news from The Hill {beacon} Health Care The Big Story Voters lean in favor of codifying Trump's MFN policy A new poll shows there is strong bipartisan support among battleground voters for Congress to codify President Trump’s “most favored nation” drug pricing policy, which would require pharmaceutical companies to lower the prices they charge Americans to...
Newly released state enrollment data show ObamaCare coverage losses could be even more severe than initially anticipated, due to Congress's unwillingness to renew enhanced subsidies. Monthly enrollment data through April from Arkansas, Colorado, Maryland, Massachusetts, New Mexico and New York showed a significant number of people canceled their coverage or did not pay their premium bills after signing up for coverage in 2026, according to an analysis from Georgetown University. Federal offic
Newly released state enrollment data show ObamaCare coverage losses could be even more severe than initially anticipated, due to Congress's unwillingness to renew enhanced subsidies. Monthly enrollment data through April from Arkansas, Colorado, Maryland, Massachusetts, New Mexico and New York showed a significant number of people canceled their coverage or did not pay their premium bills after signing up for coverage in 2026, according to an analysis from Georgetown University. Federal officials have so far only released...
An influential conservative think tank contends that a quarter of all ObamaCare exchange enrollments were improper, adding more fuel to claims from the Trump administration and GOP lawmakers that the exchanges are rife with fraud. The Paragon Health Institute's report found more than 6 million people were improperly enrolled in the health law’s exchanges in 2026. The report also argued taxpayers will improperly subsidize the Affordable Care Act program by nearly $25...
An influential conservative think tank contends that a quarter of all ObamaCare exchange enrollments were improper, adding more fuel to claims from the Trump administration and GOP lawmakers that the exchanges are rife with fraud. The Paragon Health Institute's report found more than 6 million people were improperly enrolled in the health law’s exchanges in 2026. The report also argued taxpayers will improperly subsidize the Affordable Care Act program by nearly $25...